1192590-72-9

Basic information

• Product Name: (R)-N-(4-iodo)benzyl 2-N-(tert-butoxycarbonyl)amino-3-hydroxypropionamide
• Synonyms: (R)-N-(4-iodo)benzyl 2-N-(tert-butoxycarbonyl)amino-3-hydroxypropionamide
• CAS NO: 1192590-72-9
• Molecular Weight: 420.247
• Mol File: 1192590-72-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (R)-N-(4-iodo)benzyl 2-N-(tert-butoxycarbonyl)amino-3-hydroxypropionamide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-N-(4-iodo)benzyl 2-N-(tert-butoxycarbonyl)amino-3-hydroxypropionamide(1192590-72-9)
• EPA Substance Registry System: (R)-N-(4-iodo)benzyl 2-N-(tert-butoxycarbonyl)amino-3-hydroxypropionamide(1192590-72-9)

Safety Data

• Hazardous Substances Data: 1192590-72-9(Hazardous Substances Data)

Upstream product

• 3262-72-4 (R)-N-tert-butoxycarbonyl serine 
• 59528-27-7 p-iodobenzylamine hydrochloride 
• 411221-85-7 2-(4-iodobenzyl)-isoindoline-1,3-dione 
• 54589-53-6 4-iodobenzyl chloride 

Downstream Products

• 1192590-76-3 (R)-N-(4-iodo)benzyl 2-N-(tert-butoxycarbonyl)amino-3-methoxypropionamide 
• 1192590-80-9 (R)-N-4'-(iodo)benzyl 2-acetamido-3-methoxypropionamide 
• 1197982-72-1 (R)-N-4-(3-methoxyprop-1-ynyl)benzyl 2-acetamido-3-methoxypropionamide 
• 1197982-73-2 (R)-N-4-(3-methoxypropyl)benzyl 2-acetamido-3-methoxypropionamide 

Relevant articles and documents

METHODS OF TREATMENT OF NEUROLOGICAL DISORDERS

Embodiments of the present invention provide compounds, pharmaceutical compositions, and methods of use thereof in treating neurological disorders such as epilepsy and neuropathic pain. Compounds and pharmaceutical compositions as neuroprotective agents a

NOVEL N-BENZYLAMIDE SUBSTITUTED DERIVATIVES OF 2-(ACYLAMIDO)ACETIC ACID AND 2-(ACYLAMIDO)PROPIONIC ACIDS: POTENT NEUROLOGICAL AGENTS

A first aspect of the invention is a compound (sometimes also referred to herein as an "active agent" or "active compound") of Formula (I) or ( Ia): or a pharmaceutically acceptable salt or prodrug thereof. Compositions thereof and methods of using the same (e.g. for the treatment of a neurological disease) are also described.